Saturday, 20 October 2018
Latest news
Main » Walgreens Boots Alliance, Inc. (NASDAQ:WBA) reported Sales of 118.21 Billion

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) reported Sales of 118.21 Billion

14 November 2017

Needham & Company LLC reissued a "buy" rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, October 12th. Jefferies maintained Walgreens Boots Alliance Inc (NASDAQ:WBA) on Friday, October 27 with "Buy" rating. Further considering price values, current asset values does not support Walgreens Boots Alliance Inc (NASDAQ:WBA) core strength, PB is above sector average at 2.73. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) earned "Outperform" rating by Robert W. Baird on Thursday, October 19.

8 number of analysts have estimated the sales of the company for the quarter ending Jan 3, 2018- Jan 8, 2018, analysts estimated mean sale target of 34002.4 million while high and low sale targets are estimated at 36234 million and 32541.1 million respectively. The expected WBA's profit could reach $1.27 billion giving the stock 13.94 P/E in the case that $1.26 earnings per share is reported. Short-term as well long term shareholders always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded N/A as current ratio and on the opponent side the debt to equity ratio was 0.06 and long-term debt to equity ratio also remained 0.06. Walgreens Boots Alliance (WBA)'s Williams %R presently stands at -34.57.

More news: No Xbox One X Bundles will be released this holiday season

After a recent scan, we can see that Walgreens Boots Alliance, Inc. The company has market cap of $70.85 billion. During the same period in the prior year, the company posted $1.07 EPS. It also demonstrates a stable dividend policy for Walgreens Boots Alliance, Inc. connected to the long-run, with viable earnings.

TRADEMARK VIOLATION NOTICE: This news story was published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. & worldwide trademark & copyright legislation. The correct version of this piece of content can be accessed at

More news: Google Pixel 2 XL Just Can't Get A Break

Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. The firm current ratio calculated as 0.80, this value is acceptable if it lies in 1.3% to 3%. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.86%. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator's stock worth $102,000 after buying an additional 6 shares during the period. The share price has moved forward from its 20 days moving average, trading at a distance of 5.44% and stays -3.96% away from its 50 days moving average. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The rating was maintained by Citigroup on Thursday, November 2 with "Buy". The shares were sold at an average price of $81.30, for a total transaction of $168,047.10. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this purchase can be found here.

Several hedge funds have recently made changes to their positions in the business.

More news: Studs and Duds from Bears' Week 10 loss to Packers

Investors may be interested in viewing the Gross Margin score on shares of Walgreens Boots Alliance, Inc. Narrowing in a bit closer, the 5 month price index is 0.85491, the 3 month is 0.87699, and the 1 month is now 0.99556. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Walgreens Boots Alliance by 2.6% in the first quarter. The company has a consensus rating of Buy and a consensus price target of $87.63. Westside Investment Management Inc. raised its position in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator's stock worth $107,000 after buying an additional 100 shares during the period. An example is a stock in a big technology company. With company PE at 18.8 shows that investors are paying $18.8 for dollar of earnings company generates, however if you see Walgreens current market price, it suggest Investors might not hope for ton of growth from company causing current discounted price. The Firm is a pharmacy-led health and wellbeing company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).